ask="N/A"
ask_size="N/A"
average_daily_volume="521189"
bid="55.00"
bid_size="4900"
book_value="11.38"
change="+2.28"
change_from_200_day_moving_average="3.74"
change_from_50_day_moving_average="1.62"
change_from_52_week_high="-13.11"
change_From_52_week_low="27.14"
change_in_percent="+3.19%"
close="73.66"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-5.88"
ebitda="-230.87M"
eps_estimate_current_year="-6.14"
eps_estimate_next_quarter="-1.68"
eps_estimate_next_year="-6.72"
ex_dividend_date="N/A"
float_shares="37661000"
high="73.89"
high_52_weeks="86.77"
last_trade_date="2/9/2017"
last_trade_price="73.66"
last_trade_size="21127"
last_trade_time="4:00pm"
low="71.52"
low_52_weeks="46.52"
market_capitalization="3.01B"
moving_average_200_day="69.92"
moving_average_50_day="72.04"
name="Ultragenyx Pharmaceutical Inc."
notes="N/A"
one_year_target_price="92.73"
open="71.52"
pe_ratio="N/A"
peg_ratio="-0.40"
percent_change_from_200_day_moving_average="+5.36%"
percent_change_from_50_day_moving_average="+2.24%"
percent_change_from_52_week_high="-15.11%"
percent_change_from_52_week_low="+58.34%"
previous_close="71.38"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="6.27"
price_per_sales="22785.28"
revenue="128000.00"
shares_outstanding="40859000"
short_ratio="12.30"
stock_exchange="NMS"
symbol="RARE"
volume="1054966"
weeks_range_52="46.52 - 86.77"
